You are here

Article info

Article menu
XML
Health technology assessment
Original research
Patient access to gene therapy medicinal products: a comprehensive review

Authors

  1. Correspondence to Dr Marta Carvalho, Departamento de Ciências Farmacológicas, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof Gama Pinto, 1649-003, Lisboa, Portugal; marta.carvalho{at}campus.ul.pt
View Full Text

Citation

Carvalho M, Sepodes B, Martins AP
Patient access to gene therapy medicinal products: a comprehensive review
BMJ Innovations 2021;7:123-134.

Publication history

  • Received February 10, 2020
  • Revised September 5, 2020
  • Accepted September 22, 2020
  • First published October 27, 2020.
Online issue publication 
January 18, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.